Peter H. Johnson

488 total citations
7 papers, 324 citations indexed

About

Peter H. Johnson is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Peter H. Johnson has authored 7 papers receiving a total of 324 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 2 papers in Molecular Biology and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Peter H. Johnson's work include Cancer Risks and Factors (2 papers), Lung Cancer Treatments and Mutations (2 papers) and Advanced Biosensing Techniques and Applications (1 paper). Peter H. Johnson is often cited by papers focused on Cancer Risks and Factors (2 papers), Lung Cancer Treatments and Mutations (2 papers) and Advanced Biosensing Techniques and Applications (1 paper). Peter H. Johnson collaborates with scholars based in United States and United Kingdom. Peter H. Johnson's co-authors include Henry M. Kuerer, Lavinia P. Middleton, George H. Perkins, Karin Hahn, Gabriel N. Hortobágyi, Nancy Gordon, Wei Yang, Mildred Ramírez, Richard L. Theriault and Andrew I. Lawton and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Clinica Chimica Acta.

In The Last Decade

Peter H. Johnson

7 papers receiving 309 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Peter H. Johnson United States	5	246	126	92	77	69	7	324
Elissa McMurtrie Canada	11	149 0.6×	75 0.6×	50 0.5×	41 0.5×	23 0.3×	15	383
Mei‐Tzu C. Tang United States	10	231 0.9×	41 0.3×	24 0.3×	62 0.8×	109 1.6×	26	379
Hatem A. Azim Italy	7	329 1.3×	50 0.4×	94 1.0×	70 0.9×	109 1.6×	14	538
Marion Gambart France	9	93 0.4×	45 0.4×	79 0.9×	83 1.1×	62 0.9×	22	265
Eduardo Paulino Brazil	11	89 0.4×	58 0.5×	13 0.1×	71 0.9×	47 0.7×	33	291
Jelena Lazić Serbia	11	57 0.2×	19 0.2×	69 0.8×	68 0.9×	37 0.5×	36	248
Christianne Lok Netherlands	12	104 0.4×	33 0.3×	174 1.9×	48 0.6×	32 0.5×	23	375
Teresa C. Longoria United States	9	168 0.7×	65 0.5×	12 0.1×	48 0.6×	25 0.4×	14	308
Priya Chacko India	7	78 0.3×	37 0.3×	48 0.5×	318 4.1×	76 1.1×	8	387

Countries citing papers authored by Peter H. Johnson

Since Specialization

Citations

This map shows the geographic impact of Peter H. Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter H. Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter H. Johnson more than expected).

Fields of papers citing papers by Peter H. Johnson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter H. Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter H. Johnson. The network helps show where Peter H. Johnson may publish in the future.

Co-authorship network of co-authors of Peter H. Johnson

This figure shows the co-authorship network connecting the top 25 collaborators of Peter H. Johnson. A scholar is included among the top collaborators of Peter H. Johnson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter H. Johnson. Peter H. Johnson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Hoang, Tien, Toby C. Campbell, Chong Zhang, et al.. (2013). Vorinostat and bortezomib as third-line therapy in patients with advanced non-small cell lung cancer: a Wisconsin Oncology Network Phase II study. Investigational New Drugs. 32(1). 195–199. 34 indexed citations

2.

Oettel, Kurt R., Jules H. Blank, HG Ahuja, et al.. (2011). Vorinostat (V) and bortezomib (B) as third-line treatment in patients with advanced non-small cell lung cancer (NSCLC): A Wisconsin Oncology Network Phase II Study.. Journal of Clinical Oncology. 29(15_suppl). 7567–7567. 3 indexed citations

3.

Johnson, Peter H. & Francisco J. Esteva. (2007). The use of HER2 modulation in the adjuvant setting. Current Oncology Reports. 9(1). 9–16. 3 indexed citations

4.

Hahn, Karin, Peter H. Johnson, Nancy Gordon, et al.. (2006). Treatment of pregnant breast cancer patients and outcomes of children exposed to chemotherapy in utero. Cancer. 107(6). 1219–1226. 244 indexed citations

5.

Johnson, Peter H., Karin Gwyn, Lavinia P. Middleton, et al.. (2005). The treatment of pregnant women with breast cancer and the outcomes of the children exposed to chemotherapy in utero. Journal of Clinical Oncology. 23(16_suppl). 540–540. 4 indexed citations

6.

Johnson, Peter H., et al.. (1999). Handbook of Geriatric Nursing Care. 7 indexed citations

7.

Strange, Richard C., et al.. (1982). Studies on the variability of glutathione S-transferase from human erythrocytes. Clinica Chimica Acta. 120(2). 251–260. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact